This not only was confirmed by a study in which mice given ventilation support increased their risk of secondary bacterial infection, but also suggests that TLR4 could indirectly be a potential therapeutic target, via treatment with TLR4 antagonists [183]. The gene discussed is TLR4; the disease is bacterial infectious disease.